Hep Email Update Albumin and Liver Stiffness Signal Risk of Liver Cancer After Hep C Cure So found a study of more than 1,500 people treated for hep C, including almost 600 people with compensated advanced chronic liver disease. Advertisement Weight Loss Is Tied to Improved Liver Enzymes in Those With Hep B Normalizing ALT liver enzyme levels is associated with positive long-term outcomes. Combination Therapy Holds Promise for People With Hepatitis D Lonafarnib and bulevirtide, when used with pegylated interferon, reduced hepatitis delta levels in two studies. Going Global Personal struggles with liver disease led Donna Cryer to advocacy. Hep Winter 2019 Read the latest issue! Hep Stories: Get inspired Advertisement Treatment News Screening for Hepatitis B Before Chemotherapy Is Cost Effective Combination Therapy Holds Promise for People With Hepatitis D U.S. Prescription Opioid Use Rates Have Stabilized Weight Loss Is Tied to Improved Liver Enzymes in Those With Hep B Newsfeed Senate Confirms Stephen Hahn as FDA Head Are Medicare Plans Better Called Medicare Disadvantage Plans? Michigan Steps Up Harm Reduction to Combat Opioid Crisis AI May Mitigate Theft of Opioids by Hospital Employees Treatment News Screening for Hepatitis B Before Chemotherapy Is Cost Effective Combination Therapy Holds Promise for People With Hepatitis D U.S. Prescription Opioid Use Rates Have Stabilized Weight Loss Is Tied to Improved Liver Enzymes in Those With Hep B Newsfeed Senate Confirms Stephen Hahn as FDA Head Are Medicare Plans Better Called Medicare Disadvantage Plans? Michigan Steps Up Harm Reduction to Combat Opioid Crisis AI May Mitigate Theft of Opioids by Hospital Employees

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: